-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On October 12, the State Food and Drug Administration issued the No.
The original text is as follows:
The original text is as follows:Announcement of the State Food and Drug Administration on 7 batches of drugs not in compliance with the regulations (No.
After inspection by 4 drug inspection institutions including the Hunan Provincial Institute of Drug Inspection, 7 batches of drugs including orlistat capsules produced by 5 companies including Zhongshan Wanhan Pharmaceutical Co.
1.
After inspection by Dalian Drug Inspection and Testing Institute, a batch of chloroquine phosphate tablets produced by Sancai Shiqi Pharmaceutical Co.
After inspection by Wuhan Institute of Drugs and Medical Devices Inspection, a batch of compound licorice oral solution produced by Qinghai Baojiantang Sinopharm Co.
The first batch of cough syrup produced by Wuhu Zhang Hengchun Pharmaceutical Co.
2.
3.
List of 7 batches of non-compliant drugs
